2002
DOI: 10.1001/archderm.138.9.1158
|View full text |Cite
|
Sign up to set email alerts
|

Corticosteroid-Sparing Effect of Intravenous Immunoglobulin Therapy in Patients With Pemphigus Vulgaris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
79
0
4

Year Published

2003
2003
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(85 citation statements)
references
References 44 publications
(45 reference statements)
2
79
0
4
Order By: Relevance
“…Association of IVIG with acute renal failure mandates careful evaluation of the benefit/ risk ratio in patients with a history of renal disease. [20][21][22] Rituximab is a monoclonal antibody against the CD20 antigen on mature B cells. Treatment with this agent is often effective in AIBD.…”
Section: Corticosteroid-sparing Agents and Their Side Effectsmentioning
confidence: 99%
“…Association of IVIG with acute renal failure mandates careful evaluation of the benefit/ risk ratio in patients with a history of renal disease. [20][21][22] Rituximab is a monoclonal antibody against the CD20 antigen on mature B cells. Treatment with this agent is often effective in AIBD.…”
Section: Corticosteroid-sparing Agents and Their Side Effectsmentioning
confidence: 99%
“…8 Adjuvant intravenous immunoglobulins (IVIg) have been proposed as a therapeutic alternative, and achieved clinical disease control and corticosteroidsparing, but not prolonged complete remission (CR) without treatment. 9,10 Rituximab (RTX), a monoclonal antibody directed against the CD20 antigen expressed on B lymphocytes, was recently shown to be effective against severe pemphigus, using either multiple cycles combined with IVIg 11 or a single cycle. 12 However, its long-term efficacy, particularly the possibility of prolonged CR with or without maintenance therapy, remains to be proven.…”
mentioning
confidence: 99%
“…2 No well-controlled, double-blind clinical study to demonstrate the efficacy of HD-IVIG has been conducted. [3][4][5][6][7][8][9][10][11][12][13] This is because: (1) pemphigus is a rare intractable disease;…”
mentioning
confidence: 99%